Abstract:Mesenchymal stromal cells (MSCs) are an attractive option for cell therapy for type 1 diabetes mellitus (DM). These cells can be obtained from many sources, but bone marrow and adipose tissue are the most studied. MSCs have distinct advantages since they are nonteratogenic, nonimmunogenic and have immunomodulatory functions. Insulin-producing cells (IPCs) can be generated from MSCs by gene transfection, gene editing or directed differentiation. For directed differentiation, MSCs are usually cultured in a glucose-rich medium with various growth and activation factors. The resulting IPCs can control chemically-induced diabetes in immune-deficient mice. These findings are comparable to those obtained from pluripotent cells. PD-L1 and PD-L2 expression by MSCs is upregulated under inflammatory conditions. Immunomodulation occurs due to the interaction between these ligands and PD-1 receptors on T lymphocytes. If this function is maintained after differentiation, life-long immunosuppression or encapsulation could be avoided. In the clinical setting, two sites can be used for transplantation of IPCs: the subcutaneous tissue and the omentum. A 2-stage procedure is required for the former and a laparoscopic procedure for the latter. For either site, cells should be transplanted within a scaffold, preferably one from fibrin. Several questions remain unanswered. Will the transplanted cells be affected by the antibodies involved in the pathogenesis of type 1 DM? What is the functional longevity of these cells following their transplantation? These issues have to be addressed before clinical translation is attempted. Graphical Abstract Bone marrow MSCs are isolated from the long bone of SD rats. Then they are expanded and through directed differentiation insulin-producing cells are formed. The differentiated cells are loaded onto a collagen scaffold. If one-stage transplantation is planned, a drug delivery system must be incorporated to ensure immediate oxygenation, promote vascularization and provide some growth factors. Some mechanisms involved in the immunomodulatory function of MSCs. These are implemented either by cell to cell contact or by the release of soluble factors. Collectively, these pathways results in an increase in T-regulatory cells.

Mouse islet‐derived stellate cells are similar to, but distinct from, mesenchymal stromal cells and influence the beta cell function

Isolation and characterization of human islet stellate cells.

Isolation and Characterization of Islet Stellate Cells in Rat

Bone marrow-derived mesenchymal stem cells protect allogenic islets

Islet Stellate Cells Regulate Insulin Secretion Via Wnt5a in Min6 Cells

The Immunoregulation of Syngenic Bone Marrow Mesenchymal Stem Cells on Allogenic Islets Induced T Lymphocytes

Islet Stellate Cells Isolated from Fibrotic Islet of Goto-Kakizaki Rats Affect Biological Behavior of Beta-Cell

A Transcriptional Sequencing Analysis of Islet Stellate Cell and Pancreatic Stellate Cell.

Bone marrow mesenchymal stem cells promote the repair of islets from diabetic mice through paracrine actions.

Mesenchymal Stem Cells Ameliorate Β Cell Dysfunction of Human Type 2 Diabetic Islets by Reversing Β Cell Dedifferentiation

Potential roles of mesenchymal stromal cells in islet allo- and xenotransplantation for type 1 diabetes mellitus

Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells in Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia

Advancing diabetes treatment: the role of mesenchymal stem cells in islet transplantation

Recent progress in differentiation of mesenchymal stem cells into islet-like cells

Secretome analysis of human and rat pancreatic islets co-cultured with adipose-derived stromal cells reveals a signature with enhanced regenerative capacities

Multipotent Mesenchymal Stromal Cells Interact and Support Islet of Langerhans Viability and Function

From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges

iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation.

The Effect of Mouse Bone Marrow-Derived Mesenchymal Stem Cells on Islet Graft Rejection

Mesenchymal Stem Cells Contribute to Insulin-Producing Cells Upon Microenvironmental Manipulation in Vitro.

Controlling human stem cell-derived islet composition using magnetic sorting